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Abstract The patient with head and neck (H&N) cancer is prone to psychological
distress immediately following diagnosis and during the treatment phase. Lowered
mood is typical and tends to extend beyond the treatment phase. There is little
evidence for a specific treatment method predicting a characteristic psychological
response. Rather, patients’ reactions vary widely according to fears of recurrence,
health beliefs, personality, coping and available support. Patient reports of quality
of life show a return to pre-treatment status after a year but are determined to
some degree by initial depression levels and dispositional factors such as optimism.
Information provided to patients (e.g. leaflets, booklets of written guidance) by
specialist treatment centres about the disease and its management require
sustained effort in their design and distribution. Our understanding of patient
responses to this disease has improved and has assisted in the development of
psychological interventions. Controlled trials will provide important evidence of
the components, effects and sustainability of these experimental programmes,
and improve overall care plans for this often neglected patient group.
ª 2006 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
The treatment of patients diagnosed with head
and neck (H&N) cancer presents challenges to the
surgical team. Successful outcome is assessed by
traditional survival rates and by additional factors
notably morbidity, functional status and quality of
life (QoL). The assessment of QoL is salient when
* Corresponding author. Tel.: þ44 1334 463565; fax: þ44 1334
463482.
E-mail address: gmh4@st-andrews.ac.uk (G.M. Humphris).1743-9191/$ - see front matter ª 2006 Surgical Associates Ltd. Pu
doi:10.1016/j.ijsu.2005.12.004the differences in survival rates between different
treatment regimens are marginal. The decision on
the method to select may then be indicated by
patient preference or known QoL improvements.
Recently, the literature on outcomes has extended
to related issues including: psychological status
and a discussion of what patients experience
during the recovery and rehabilitation phase.
This article presents a brief review of current
knowledge in this expanding field for clinicians
performing highly individualised treatments. The
aim of this brief review is to highlight theblished by Elsevier Ltd. All rights reserved.
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select the most beneficial treatment pathway for
the patient with H&N cancer.
Head and neck cancer is the sixth most common
cancer worldwide.1,2 Ninety per cent of these can-
cers are squamous cell carcinomas. Men are more
likely than women to succumb to the disease by
a ratio of 3:1. The disparity between the sexes is
becoming less pronounced in the U.K. Mortality
rates are high at 54% overall.3,4 Also, recurrence
rates are high in the first year following diagnosis
of the primary tumour, compared to many other
cancers.
Detection and treatment
Primary care doctors detect most tumours on
complaint of soreness in the mouth or throat by
their patients. However, on enquiry GMPs preferred
that this task associated with any oral symptoms
should be themajor remit of the dentist.5 A numberof psychological factors explain the delay of pa-
tients with advanced H&N cancer seeking medical
care. Patients who delay more than 3 months tend
to be less optimistic, less committed or involved
in health activities (termed ‘health hardy’), cope
less actively and seek less support, compared
to those who seek medical attention within
3 months.6 The management of H&N cancer relies
strongly on surgery or radiotherapy, or their com-
bination (see Fig. 1).7 Surgical intervention aims
to completely remove the primary cancer and any
involved lymph nodes. Preservation of function is
a secondary aim and finally the maintenance of
aesthetics. Many H&N cancer patients are treated
with high-dose radiotherapy, which as a conse-
quence also irradiates associated sensitive tissues
such as mucous membranes, nerves and circulatory
structures.8 Increasing intensity of treatment has
produced significant improvements to outcome
but has raised side effects.8 Delay (greater than
6 weeks) in starting radiotherapy following surgery
has been shown to be detrimental to 5-year localFigure 1 (a) Squamous cell carcinoma of the left posterior mandible. (b) Mandibular resection with reconstruction.
(c) Postoperative panoral radiograph showing placement of plants and implants. (d) Six months post surgery, showing
good aesthetic results.
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disease stage are known to influence treatment
selection but not co-morbidity or pre-treatment
QoL.10
Psychological morbidity associated
with diagnosis and treatment
An important threat to the overall well being of
patients with H&N cancer is increased psycholog-
ical distress.11,12 The level of psychological mor-
bidity in patients with this cancer has been
studied.13e15 H&N cancer patients who have seri-
ous disease or who live alone were found to be
more likely to suffer psychological distress (odds
ratios of 5.77 and 4.83, respectively). The immedi-
ate impact of diagnosis and treatment is an impor-
tant phase for detailed study.16
A high incidence of anxiety (35%) soon after
diagnosis and peak levels of depression (30%) about
3 months following initial treatment have been re-
ported.16 Anxiety rises soon after diagnosis,
whereas depression takes 3 months to reach
a peak. The rates of both constructs return almost
to pre-treatment level by 12 months. Humphris
and Rogers17 showed comparable rates at 3 months
following treatment. Distress (30% ‘cases’) has
been found in long term survivors (>6 years).18
The use of self-rating scales may underestimate
the effects of treatments as detailed interviews
have revealed greater levels of distress in a
reported in-depth study.19
Factors that influence psychological
distress
A number of psychosocial variables have been
clearly implicated in the development of anxiety
and depression in this group. These include:
information needs, fears of recurrence, quality
of life, self-care behaviour, coping, personality,
appearance, and social support.
Information needs
Patients vary considerably in the extent of the
information that they wish to receive from health
care providers.20 Some evidence suggests that the
adequacy of information received by H&N cancer
patients has implications for positive recovery
some 2e6 years later.21 In addition, in a review
of psychological factors related to QoL it was con-
cluded that information needs were especially
pertinent as these were modifiable.22 Although
patients may not appear to exhibit detailedknowledge of the options available for treatment,
or the recommended practices for rehabilitation
and aftercare following initial treatment, they
will have their own beliefs and expectations. These
may be based upon the experiences of family
members and/or friends who may have suffered
from other cancers. Hence, the range and types
of treatments that these associated supporters
may have experienced could differ significantly
from those recommended to the patient with
H&N cancer. Patients frequently suffer undue
anxiety because they find the treatment incompre-
hensible. The uncertainty is partially a function of
the limited supply of information in a form that
the patient understands.23 A number of authorities
and voluntary groups have produced electronically
accessible versions of leaflets and booklets aimed
at patients at all stages of the diagnostic and treat-
ment process. However, it is not known whether
the typical H&N cancer patient will have access
or the computer skills to utilise these resources.
In a recent study, a selected sample of H&N
cancer patients reported that they were relatively
well informed about the surgical treatment they
received but felt less prepared for the extended
lifestyle changes. Information and guidance during
the 3e6-month postoperative period needed to be
improved. The patients did not sense that there
may have been a chance for them to express an
opinion over a possible choice of treatment. Those
who expressed a wish to be active in this way felt
they could not obtain the necessary information to
assist them in this more active role which could
involve discussions, for example, of survival trade-
off for maintaining greater function.24
Recurrence fears
Once treatment has been completed and the
patient discharged, both patient and carer may
express relief. However, this eagerly awaited step
can generate anxiety and distress.25 The stage has
been referred to as the ‘neutral time’ when recur-
rence fears surface.26 Some evidence suggests that
fears of recurrence are a major concern,27 and in
one survey fear of recurrence was the most fre-
quently ranked concern of 13 concerns listed.28
Furthermore, patients treated for a malignancy
not less than six months previously, 42% reported
that fears of recurrence were their greatest con-
cern.29 Maguire and colleagues have shown that
health-related concerns have the potential to
cause depression.30 An episode of depression can
be precipitated when these health concerns are
resisted expression during contact with the health
care services.
40 G.M. Humphris, G. OzakinciA cognitive formulation has been proposed to
explain how patients’ fears of recurrence are
raised.31 Strikingly, the patients described their
experience of recovery as being peppered with
frequent false alarms triggered by unusual sensa-
tions, including tingling, pins and needles, rapid
swelling, and sensitivity to hot and cold. These
sensations were interpreted as indicators of new
symptoms and the return of the cancer. This pat-
tern of experiences fits the Common Sense Model
of Illness developed by Leventhal and colleagues
where physical symptoms may trigger emotional
reactions such as fears of recurrence.32e34
A high incidence of recurrence fears is un-
related to the extent of the disease or when the
diagnosis was made has been reported.35 Two
years later these fears are found to be relatively
stable (rs ¼ 0.7).36 The point prevalence of con-
cerns about the cancer returning is 65% in both
the baseline and 2-year follow-up samples. This
is consistent with other reports of long-term survi-
vors of H&N cancer.37
Though the risk of recurrence is a vital issue for
patients, this concern is not always immediately
obvious to the clinician.38 Patients may keep
recurrence concerns to themselves or deny the
possibility of a recurrence. Staff may collude and
avoid discussing the topic of recurrence.
Quality of life
In the H&N cancer field patients’ QoL research has
increased rapidly.39 A range of measures specific to
this cancer have received critical review39 and
associated studies presented.13,40 Much of this lit-
erature has focused on single issues. For example,
long term QoL appears not to vary greatly with age
of patient. Such a finding would support providing
identical treatments to all age groups.41 Likewise,
dental status has an impact on the QoL of 5-year
H&N cancer survivors.42 Some attempt has been
made to convert raw QoL scores to more meaning-
ful clinically significant benchmarks, which will
strengthen the adoption of these assessments.43
A Swedish longitudinal study of QoL has been
reported44 including anxiety and depression indi-
ces. Two-thirds of the patients remained alive to
study completion. The health related quality of
life (HRQoL) scales attained their lowest level im-
mediately after treatment. Virtually all of the sub-
scales returned to their pre-treatment levels within
a year. Dry mouth, sexual responsiveness and denti-
tion were resisted improvement over time. After
1 year post treatment the HRQoL levels remained
relatively stable. Mental distress and global quality
of life were the most significant improvements overthe 3-year duration. Depression and physical func-
tioning at baseline predicted independently global
QoL at 3 years. Patients with advanced disease
(Stages III and IV) scored poorly on virtually all
HRQoL domains. Other longitudinal studies tracking
HRQoL adopting standardised instruments have
reported a rise of QoL on virtually all domains to
pre-treatment levels after 1 year post treatment.45
Raised depressive symptoms at pre-treatment
predicted similar difficulties at 6 and 12 months
later, including physical functioning.46 Prediction
of depressed status was 81% and 67% at the two
time periods, 6 and 12 months respectively. These
percentages increased to 89% and 82% if the pa-
tients’ physical symptoms at the time of assess-
ment were entered into the explanatory model.
The routine screening of psychosocial variables
and physical symptoms before treatment are rec-
ommended to identify patients who may be sus-
ceptible to depression on recovery from surgery
and/or radiotherapy for H&N cancer.47
An interesting finding in a 6-year longitudinal
study with H&N cancer patients was that the
intensity of a number of psychosocial complaints,
such as feeling angry, irritable, tense, and anxious,
were significantly associated with remaining re-
currence free.21 The only other variable that had
a greater predictive power was extent of nodal
metastases. A further report has shown that pa-
tient reported QoL is related to survival. Pre-treat-
ment fatigue was a significant predictor of survival
for patients with advanced H&N cancer.48
Self-care behaviour
An important study of self-care behaviour (e.g.
grooming)49 showed that in a matter of days, those
patients who started looking after themselves
made faster recoveries. Patients who tried to
cope and re-socialise needed to view themselves
close up (in a mirror), touch their own facial
defects, and expose them to others.
Coping
The commonest coping mechanisms demonstrated
in H&N cancer patients are helplessness and
fatalism (70% of patients).27 Resolution of concerns
occurs in less than 40% of the frequent concerns
expressed. Paradoxically, it is not the most seri-
ously ill patients who cope poorly. Some patients,
especially those with more advanced H&N cancer
develop more problem-focused coping abilities to
manage the adverse effects of treatment on
their global QoL.50 Patients appear to exhibit
a wide range of positive strategies to cope but they
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however, through support-based interventions.51
Personality
The disposition of H&N cancer survivors has been
shown to have some long-term effects on mood,
QoL and survival. Patients with H&N cancer re-
porting a ‘sense of humour’ at diagnosis tend to be
less depressed 6 years later.52 Pre-morbid pessi-
mism in 5-year survivors was the strongest predic-
tor of QoL measures over physical risk factors (e.g.
shoulder and neck range of motion).53 Disposi-
tional optimism predicts 1-year survival in this pa-
tient group independent of socio-demographic and
clinical variables.54 Surgical teams are advised to
take account of these character traits when organ-
ising their treatment plans and follow up support.
Appearance
There is considerable variation in the concerns that
patients express about appearance changes.55West
argues that the time spent on the ward with others
of similar status prepares the patient for discharge
into the social world on leaving the hospital.56
Other investigators have alerted clinicians to
unspoken distress from scarring and disfigurement
caused by surgery or radiotherapy. A survey of
patients over 18 months57 found that extensive dis-
ease involving neck dissection to remove involved
lymph nodes had a strong negative effect on
appearance ratings. Tumour size was less strongly
associated with appearance, but those with larger
tumours tended to rate themselves less positively
than those with small tumours.57 This work is
consistent with a Canadian study where patients
were found to show a strong association between
the level of disfigurement and depression.58
Social support
The interpersonal relationship of the H&N cancer
patient with their spouse/partner seems an im-
portant determinant of whether to seek consulta-
tion initially. In addition, the ability to sustain
a recovery from the treatment of H&N cancer is
crucially dependent on the level of support to
which the patient has access.59 Both surgery and
radiotherapy to the face and neck influence impor-
tant structures responsible for the self-image of
the individual.60 In addition, the ability of the pa-
tient to resume social activity can be markedly
undermined. This particular cancer challenges
many ways that patients may wish to communi-
cate. Available support has been shown to leadto less depressive symptomology in patients fol-
lowed from diagnosis to 6 months later.61 This
association was strongest in patients with few
physical complaints. Received support, however,
was unrelated to depression, leading the authors
to believe that support may be detrimental in
those with few physical complaints. The provision
of support, therefore, needs to be targeted appro-
priately rather than offered indiscriminately.
Psychological interventions
There have been many calls for introducing
greater emotional support for H&N cancer pa-
tients.12,27,62,63 Pilot work describing the design
and implementation of two types of intervention
have been reported with some encouraging prelim-
inary results.64 The first tested the effect of long-
term group psychotherapy with newly diagnosed
patients. The greatest improvement was emotional
functioning in the intervention group compared
to the controls. The second study investigated
a 1-week psycho-educational programme delivered
1 year following surgery. Positive changes on anxi-
ety and depression were reported. Both interven-
tions require randomised controlled studies to
confirm these effects.
A psychosocial support programme was evalu-
ated with H&N cancer patients using a longitudinal,
prospective, case-control design.65 The support
programme consisted of visits from the cancer
team, including a weekly visit during treatment
and then once a month for the first 6 months
following treatment, and then again 1 and 3 years
after diagnosis. At 1 year follow-up the control
group had a clinically and statistically better
global QoL score. This difference was not sustained
at 3 years. One explanation offered was that the
study group patients became dependent on the
visits as satisfaction levels with the intervention
were high at 1 year whereas QoL did not improve.
The authors stressed the need for improved train-
ing for hospital personnel to recognise patients
with affective disorders. In support of this view,
a further intervention to improve nutrition in
patients with H&N cancer only found a significant
longer term effect on QoL when the advice given
was delivered by a counsellor.66
The ‘adjustment to fears, threat and expecta-
tion of recurrence’ (AFTER) intervention was
designed to identify and reduce patients’ fears of
recurrence following primary treatment for orofa-
cial cancer.17 The intervention consisted of six
structured sessions to be delivered by a specialist
nurse and featured the encouragement of the
42 G.M. Humphris, G. Ozakincipatient to express their concerns over future dis-
ease. The randomised controlled trial to test the
intervention demonstrated a short-term effect
that reduced cancer worries, anxious preoccupa-
tion and increased global QoL. To the authors’
knowledge at the time of writing there are two
major psychologically based RCTs with H&N cancer
patients. These are being conducted in Montreal,
Canada67 and Utrecht, The Netherlands (de Leeuw
and coworkers), and will provide further evidence
for the role of structured psychological support.
Conclusion
The surgeon faces many dilemmas when approach-
ing the treatment of the patient with head and
neck cancer. Not only are there numerous de-
cisions to take surrounding the surgical plan but
also the total care package will include reference
to wider issues including the psychological status
of the patient. This review has introduced some of
the key factors that clinicians should be aware of
to ensure the overall health of the patient.
Attention to detailed assessment within the team
to maintain an individualised approach and also to
introduce more systematic and targeted service
provision such as psychological interventions are
considered as achievable aims for improving head
and neck cancer services.
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